Fulltext
The full text of this article is available on the PDF file.
Zahedan Journal of Research in Medical Sciences
The Official Journal of Zahedan University of Medical Sciences
e-ISSN 2383-2894
Outline
Determining the diagnostic value of alkaline phosphatase in comparison with parathyroid hormone (PTH) of renal osteodystrophy for treatment with calcitriol in hemodialysis patients
Authors
1Department of Internal Medicine Shaheed Sadoughi University of Medical Sciences & Health Services, Yazd, Iran.
2Department of Internal Medicine, Faculty of medicine, Zahedan University of Medical Sciences and health Services, Zahedan, Iran.
*Corresponding Author: Department of Internal Medicine Shaheed Sadoughi University of Medical Sciences & Health Services, Yazd, Iran. Email: [email protected]
Published online:Sep 27, 2006
Article type:Research Article
Received:Jun 04, 2006
Accepted:Aug 28, 2006
How to Cite:Nouri-Majalan N, Sanadgol H. Determining the diagnostic value of alkaline phosphatase in comparison with parathyroid hormone (PTH) of renal osteodystrophy for treatment with calcitriol in hemodialysis patients. Zahedan J Res Med Sci. 2006;8(4):e94882. doi:
Abstract
Background: Serum parathyroid hormone (PTH) is one of the most important tests for treatment
of hemodialysis patients with calcitriol. This drug should be started when the PTH>200 pg/ml.
However, the appropriate level of serum alkaline phosphates (ALP) for starting calcitriol is
unclear. The aim of this study was to determine serum ALP as cutoff point for treatment of
secondary hyperparathyroidism with calcitriol.
Method and Material: This study was a cross sectional. The serum level of PTH and ALP were
measured in 75 chronic hemodialysis patients.
Results: The correlation between PTH and ALP in diagnosis for treatment with calcitriol was
significant (Kappa test P-Value=0.000). In determination of diagnostic value of ALP (at level
300IU/L) for treatment with calcitriol, sensitivity, specificity, positive predictive value, negative
predictive value and accuracy were 88.9%, 93.9%, 66.7%, 98.4% and 93.3%, respectively. The
cutoff point of ALP for treatment with calcitriol was 300 IU/L (normal 100-290 IU/L).
Conclusion: These findings suggest that serum ALP is a good test for treatment of secondary
hyperparathyroidism. The results also indicate that calcitriol administration should not be started
with ALP<300 IU/L.
References
- 1.The References of this article are available on the PDF file.
Copyright
© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
6
Feb
2017
Effects of Inactive Vitamin D on Persistent Secondary Hyperparathyroidism in Patients on Hemodialysis
Mojgan Jalalzadeh,
Nouraddin Mousavinasab
Jalalzadeh M, Mousavinasab N. Effects of Inactive Vitamin D on Persistent Secondary Hyperparathyroidism in Patients on Hemodialysis. Nephro-Urol Mon. 2017;9(2):e13156. doi: https://doi.org/10.5812/numonthly.45029
24
Dec
2016
Serum Levels of Intact Parathyroid Hormone, Calcium, and Phosphorus and Risk of Mortality in Hemodialysis Patients
Tayebeh Soleymanian,
Neda Nikzad,
Alireza Mahjoub,
Hassan Argani,
Shokoofe Saavaj
Soleymanian T, Nikzad N, Mahjoub A, Argani H, Saavaj S. Serum Levels of Intact Parathyroid Hormone, Calcium, and Phosphorus and Risk of Mortality in Hemodialysis Patients. Nephro-Urol Mon. 2017;9(1):e42569. doi: https://doi.org/10.5812/numonthly.42569
6
Aug
2023
Calcitriol Versus Calcitriol and Low Dose Cinacalcet for Treating Severe Secondary Hyperparathyroidism in Hemodialysis Patients: A Randomized Clinical Trial
Sedighe Ebrahimi,
Maryam Montazeri,
Maryam Kabootari,
Saeid Amirkhanlou
Ebrahimi S, Montazeri M, Kabootari M, Amirkhanlou S. Calcitriol Versus Calcitriol and Low Dose Cinacalcet for Treating Severe Secondary Hyperparathyroidism in Hemodialysis Patients: A Randomized Clinical Trial. J Kermanshah Univ Med Sci. 2023;27(2):e134173. doi: https://doi.org/10.5812/jkums-134173
13
Nov
2013
The Effect of Vitamin C on Parathyroid Hormone in Patients on Hemodialysis With Secondary Hyperparathyroidism: A Double Blind, Placebo-Controlled Study
Vajihe Biniaz,
Eghlim Nemati,
Ali Tayebi,
Mehdi Sadeghi Shermeh,
Abbas Ebadi
Biniaz V, Nemati E, Tayebi A, Sadeghi Shermeh M, Ebadi A. The Effect of Vitamin C on Parathyroid Hormone in Patients on Hemodialysis With Secondary Hyperparathyroidism: A Double Blind, Placebo-Controlled Study. Nephro-Urol Mon. 2013;5(5):962-966. doi: https://doi.org/10.5812/numonthly.12404
30
Oct
2007
Left ventricular hypertrophy and calcium, phosphate related factors in chronic hemodialysis patients
HR Samimagham,
M Sahebjame,
a haghighi,
M Javidan
Samimagham H, Sahebjame M, haghighi A, Javidan M. Left ventricular hypertrophy and calcium, phosphate related factors in chronic hemodialysis patients. Zahedan J Res Med Sci. 2007;9(4):e94759. doi:
Cited by
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 0
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 0
Last Update: 1 day ago
Comments
Number of Comments:0